FINGER; Finland-Germany Myocardial Infarction Study

Acute Myocardial Infarction Clinical Trial

— FINGER  

Official title:

Finnish-German Prospective, Observational Follow-up Study on Risk Assessment of Mortality After Myocardial Infarction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00828698
• Other study ID #: Finger-96
• Status: Completed
• Phase: N/A
• First received: January 23, 2009
• Last updated: January 23, 2009
• Start date: January 1996

Study information

• Verified date: January 2009
• Source: University of Oulu
• Contact: n/a
• Is FDA regulated: No
• Health authority: Finland: Ethics CommitteeGermany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The purpose of this observational study is to find characteristics and risk stratification methods for identification of subjects who have increased risk of death, especially sudden cardiac death, after acute myocardial infarction.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. primary completion date: January 2000
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of acute myocardial infarction

• Consent to the study

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Infarction
• Myocardial Infarction

Intervention

Other:
• No intervention

Locations

Country	Name	City	State
Finland	Oulu University Hospital	Oulu
Germany	Deutsches Herzzentrum	Munich

Sponsors (6)

Lead Sponsor	Collaborator
University of Oulu	Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie, Finnish Foundation for Cardiovascular Research, German Research Foundation, Kommission für Klinische Forschung, Medical Council of the Finnish Academy of Science

Countries where clinical trial is conducted

Finland,  Germany, 

References & Publications (4)

Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006 Ma — View Citation

Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Perkiömäki JS, Schmidt G, Huikuri HV. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardio — View Citation

Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005 Apr;26(8):762-9 — View Citation

Peltola M, Tulppo MP, Kiviniemi A, Hautala AJ, Seppänen T, Barthel P, Bauer A, Schmidt G, Huikuri HV, Mäkikallio TH. Respiratory sinus arrhythmia as a predictor of sudden cardiac death after myocardial infarction. Ann Med. 2008;40(5):376-82. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All cause mortality		10years	No
Secondary	Sudden cardiac death		10 years	No